Orexigen Therapeutics, Inc.
SEC CIK 1382911 · OREXQ · last insider filing 2019-06-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Narachi Michael | Director · President and CEO | filed 2009 - 2017 |
| Dovey Brian H | Director | filed 2007 - 2017 |
| Mahaffy Patrick J | Director | filed 2009 - 2017 |
| Zoth Lota S. | Director | filed 2012 - 2017 |
| Bock Louis C | Director | filed 2007 - 2017 |
| Honig Peter | Director | filed 2010 - 2017 |
| Endicott David J. | Director | filed 2012 - 2017 |
| Jorn Debora | Director | filed 2016 - 2017 |
| Dixon Wendy L | Director | filed 2010 - 2015 |
| Weber Eckard | Director | filed 2007 - 2015 |
| Turner Daniel K III | Director | filed 2007 - 2012 |
| Powell Michael | Director | filed 2007 - 2011 |
| Lacob Joseph | Director | filed 2007 - 2011 |
| Tollefson Gary D | Director · President and CEO | filed 2007 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Moglia Stephen A. | VP, Chief Accounting Officer | filed 2016 - 2018 |
| Forbes Monica | VP & Acting CFO | filed 2018 - 2018 |
| Flynn Peter D | SVP, Dev, Reg Affairs, Safety | filed 2016 - 2017 |
| Cannell Thomas R | EVP, Chief Commercial Officer | filed 2015 - 2017 |
| Lynch Thomas P. | EVP. General Counsel & Sec. | filed 2015 - 2017 |
| Keyes Jason A | SVP, Chief Financial Officer | filed 2016 - 2017 |
| Klassen Preston | SVP, Head Global Development | filed 2010 - 2016 |
| ACE Heather S | EVP, Global Human Resources | filed 2016 - 2016 |
| Booth Mark D | Chief Commercial Officer | filed 2009 - 2015 |
| Turner Heather D | Vice President | filed 2007 - 2015 |
| Hagan Joseph P | Sr. VP, Corporate Development | filed 2009 - 2015 |
| Viveash Dawn | SVP/Head of Regulatory Affairs | filed 2009 - 2011 |
| Cooper Graham K | CFO, Treasurer, Secretary | filed 2007 - 2011 |
| Dunayevich Eduardo | Chief Medical Officer | filed 2007 - 2010 |
| Piskorski Walter | VP, Technical Operations | filed 2009 - 2010 |
| Scaife Michael C | Sr. VP, Regulatory Affairs | filed 2009 - 2009 |
| Baum Carol A | VP, Commercialization | filed 2009 - 2009 |
| KIM Dennis D | Sr. VP, Corporate Development | filed 2009 - 2009 |
| Landbloom Ronald P | VP, Medical and Regulatory | filed 2007 - 2009 |
| Cowley Michael A | Chief Scientific Officer | filed 2007 - 2008 |
| Bymaster Franklin P | VP, Neuroscience | filed 2007 - 2008 |
| Mckinney Anthony A | Chief Operating Officer | filed 2007 - 2008 |
| Lancaster James C JR | VP of Commercial Operations | filed 2007 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.